Castration Resistant Treatment

CRPC

Understanding Your Risk

When prostate cancer stops responding to ADT it is call castration-resistant.

 

Treatment options

  • Non-metastatic (nMCRPC)
  • Metastatic (M1CRPC)
  • Second-line M1CRPC
  • M1CRPC with Visceral Metastasis
  • Small Cell/Neuroendocrine

You should discuss these treatment options with your doctor for a complete understanding of the benefits and risks of each

Pin It on Pinterest